Literature DB >> 25321646

Recurrence of group B streptococcus colonization in successive pregnancies.

L C Colicchia1, D S Lauderdale2, H Du3, M Adams3, E Hirsch4.   

Abstract

OBJECTIVE: To identify risk factors for group B streptococcus (GBS) colonization in a subsequent pregnancy using microbiological and clinical data from a prior pregnancy. STUDY
DESIGN: A retrospective cohort study of women over a 10-year period, using laboratory records to identify women with GBS culture results available in two successive pregnancies. RESULT: One thousand eight hundred and ninety-four women met eligibility criteria. Of these, 1293 were not GBS-colonized in either pregnancy, 198 were colonized in both pregnancies and 403 had discordant colonization status. GBS colonization in the index pregnancy was positively associated with multiparity, premature delivery and lower maternal age and negatively associated with chorioamnionitis. The strongest predictor of colonization in a subsequent pregnancy was colonization in the index pregnancy (50% likelihood if colonized compared with 14% if not in the index pregnancy, relative risk 3.6, confidence interval (CI)=3.1 to 4.3). GBS colonization in the subsequent pregnancy was independently associated with: GBS colonization in the index pregnancy (odds ratio (OR)=6.28; CI=4.91 to 8.05), preterm delivery in the index pregnancy (OR=1.80; CI=1.05 to 3.09) and prior early pregnancy loss (OR=1.15; CI=1.04 to 1.27).
CONCLUSION: GBS colonization in a prior pregnancy is informative of colonization in a subsequent pregnancy. These data support providing antimicrobial prophylaxis in unscreened parous women with known prior GBS colonization.

Entities:  

Mesh:

Year:  2014        PMID: 25321646     DOI: 10.1038/jp.2014.185

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  21 in total

1.  Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues.

Authors:  Barbara J Stoll; Nellie I Hansen; Pablo J Sánchez; Roger G Faix; Brenda B Poindexter; Krisa P Van Meurs; Matthew J Bizzarro; Ronald N Goldberg; Ivan D Frantz; Ellen C Hale; Seetha Shankaran; Kathleen Kennedy; Waldemar A Carlo; Kristi L Watterberg; Edward F Bell; Michele C Walsh; Kurt Schibler; Abbot R Laptook; Andi L Shane; Stephanie J Schrag; Abhik Das; Rosemary D Higgins
Journal:  Pediatrics       Date:  2011-04-25       Impact factor: 7.124

2.  Prevalence of group B Streptococcus colonization in subsequent pregnancies of group B Streptococcus-colonized versus noncolonized women.

Authors:  Sarah M Page-Ramsey; Sara K Johnstone; David Kim; Patrick S Ramsey
Journal:  Am J Perinatol       Date:  2012-09-21       Impact factor: 1.862

Review 3.  Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratios by critical literature review.

Authors:  W E Benitz; J B Gould; M L Druzin
Journal:  Pediatrics       Date:  1999-06       Impact factor: 7.124

4.  The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery.

Authors:  M K Yancey; A Schuchat; L K Brown; V L Ventura; G R Markenson
Journal:  Obstet Gynecol       Date:  1996-11       Impact factor: 7.661

Review 5.  Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision analysis.

Authors:  D J Rouse; R L Goldenberg; S P Cliver; G R Cutter; S T Mennemeyer; C A Fargason
Journal:  Obstet Gynecol       Date:  1994-04       Impact factor: 7.661

6.  The epidemiology of group B streptococcal colonization in pregnancy. Vaginal Infections and Prematurity Study Group.

Authors:  J A Regan; M A Klebanoff; R P Nugent
Journal:  Obstet Gynecol       Date:  1991-04       Impact factor: 7.661

7.  Recurrence of group B streptococci colonization in subsequent pregnancy.

Authors:  Mark A Turrentine; Mildred M Ramirez
Journal:  Obstet Gynecol       Date:  2008-08       Impact factor: 7.661

8.  A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates.

Authors:  Stephanie J Schrag; Elizabeth R Zell; Ruth Lynfield; Aaron Roome; Kathryn E Arnold; Allen S Craig; Lee H Harrison; Arthur Reingold; Karen Stefonek; Glenda Smith; Melanie Gamble; Anne Schuchat
Journal:  N Engl J Med       Date:  2002-07-25       Impact factor: 91.245

9.  Perinatal group B streptococcal colonization and infection.

Authors:  J G Allardice; T F Baskett; M M Seshia; N Bowman; R Malazdrewicz
Journal:  Am J Obstet Gynecol       Date:  1982-03-15       Impact factor: 8.661

10.  Cost-effectiveness of universal prophylaxis in pregnancy with prior group B streptococci colonization.

Authors:  Mark A Turrentine; Mildred M Ramirez; Joan M Mastrobattista
Journal:  Infect Dis Obstet Gynecol       Date:  2009-12-13
View more
  5 in total

Review 1.  Perinatal Group B Streptococcal Infections: Virulence Factors, Immunity, and Prevention Strategies.

Authors:  Jay Vornhagen; Kristina M Adams Waldorf; Lakshmi Rajagopal
Journal:  Trends Microbiol       Date:  2017-06-17       Impact factor: 17.079

Review 2.  Group B Streptococcus (Streptococcus agalactiae).

Authors:  Vanessa N Raabe; Andi L Shane
Journal:  Microbiol Spectr       Date:  2019-03

3.  Safety assessment of immunization in pregnancy.

Authors:  Sonali Kochhar; Jorgen Bauwens; Jan Bonhoeffer
Journal:  Vaccine       Date:  2017-10-12       Impact factor: 3.641

4.  The prevalence and risk factors of group B streptococcus colonization in Iranian pregnant women.

Authors:  Roksana Darabi; Sima Tadi; Mitra Mohit; Erfan Sadeghi; Gita Hatamizadeh; Bahareh Kardeh; Mina Etminan-Bakhsh; Yekta Parsa
Journal:  Electron Physician       Date:  2017-05-25

5.  Association of sexually-transmitted infection and African-American race with Streptococcus agalactiae colonization in pregnancy.

Authors:  Gerald A Capraro; Sajel Lala; Khaldia Khaled; Elizabeth Gosciniak; Brianna Saadat; Sarah M Alvarez; Seema Kumar; Tara Calhoun; Edward Landry; Gloria Caldito; Joseph A Bocchini; John A Vanchiere
Journal:  Antimicrob Resist Infect Control       Date:  2020-11-04       Impact factor: 4.887

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.